PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
1.495
-0.015 (-0.99%)
At close: Feb 5, 2026

PYC Therapeutics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
153.0566.8715.5729.1118.44
Short-Term Investments
----33.07
Cash & Short-Term Investments
153.0566.8715.5729.1151.5
Cash Growth
128.86%329.47%-46.51%-43.48%102.54%
Other Receivables
24.071816.2510.070.19
Receivables
24.071816.2510.070.19
Other Current Assets
0.410.740.050.070.09
Total Current Assets
177.5385.6131.8739.2551.78
Property, Plant & Equipment
1.91.571.041.631.49
Other Intangible Assets
3.854.054.254.454.65
Other Long-Term Assets
---0.020.02
Total Assets
183.2891.2437.1745.3557.94
Accounts Payable
8.757.534.922.572.35
Accrued Expenses
2.651.263.151.380.61
Current Portion of Leases
0.40.310.180.260.19
Other Current Liabilities
0.520.010.150.170.16
Total Current Liabilities
12.329.118.414.393.3
Long-Term Leases
0.620.80.140.680.54
Pension & Post-Retirement Benefits
0.330.270.180.080.18
Total Liabilities
13.2710.188.725.154.02
Common Stock
369.59230.58140.09125.99125.99
Retained Earnings
-206.2-155.89-118.17-95.38-81.52
Comprehensive Income & Other
6.185.815.838.748.57
Total Common Equity
169.5780.527.7539.3553.04
Minority Interest
0.430.560.690.850.88
Shareholders' Equity
170.0181.0528.4440.253.92
Total Liabilities & Equity
183.2891.2437.1745.3557.94
Total Debt
1.021.110.320.940.73
Net Cash (Debt)
152.0365.7615.2628.1750.77
Net Cash Growth
131.18%331.05%-45.84%-44.52%106.14%
Net Cash Per Share
0.300.170.050.090.16
Filing Date Shares Outstanding
583.26466.61373.29318.09318.09
Total Common Shares Outstanding
583.26466.61341.65318.09318.09
Working Capital
165.2176.5123.4734.8648.48
Book Value Per Share
0.290.170.080.120.17
Tangible Book Value
165.7276.4523.534.948.39
Tangible Book Value Per Share
0.280.160.070.110.15
Machinery
4.533.553.242.812.43
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.